Orkambi Europska Unija - hrvatski - EMA (European Medicines Agency)

orkambi

vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - cistična fibroza - drugi proizvodi respiratornog sustava - tablete orkambi rezultati za liječenje муковисцидоза (mv) kod bolesnika u dobi od 6 i više godina, koji su гомозиготами na mutacije f508del u genu cftr . orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Symkevi Europska Unija - hrvatski - EMA (European Medicines Agency)

symkevi

vertex pharmaceuticals (ireland) limited - tezacaftor, ivacaftor - cistična fibroza - drugi proizvodi respiratornog sustava - symkevi is indicated in a combination regimen with ivacaftor tablets for the treatment of patients with cystic fibrosis (cf) aged 6 years and older who are homozygous for the f508del mutation or who are heterozygous for the f508del mutation and have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (cftr) gene: p67l, r117c, l206w, r352q, a455e, d579g, 711+3a→g, s945l, s977f, r1070w, d1152h, 2789+5g→a, 3272 26a→g, and 3849+10kbc→t.

Delstrigo Europska Unija - hrvatski - EMA (European Medicines Agency)

delstrigo

merck sharp & dohme b.v. - doravirine, lamivudin, Тенофовир дизопроксил фумарат - hiv infekcije - antivirusni lijekovi za liječenje hiv infekcija, kombinacija - delstrigo indiciran za liječenje odraslih osoba zaraženih hiv-1, bez prošlosti ili ovih dokaza otpornost do klase ННИОТ, lamivudin ili Тенофовир. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Paxlovid Europska Unija - hrvatski - EMA (European Medicines Agency)

paxlovid

pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.

Pifeltro Europska Unija - hrvatski - EMA (European Medicines Agency)

pifeltro

merck sharp & dohme b.v. - doravirine - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - pifeltro is indicated, in combination with other antiretroviral medicinal products, for the treatment of adults, and adolescents aged 12 years and older weighing at least 35 kg infected with hiv 1 without past or present evidence of resistance to the nnrti class.

DELSTRIGO 100 mg/1 tableta+ 300 mg/1 tableta+ 245 mg/1 tableta filmom obložena tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

delstrigo 100 mg/1 tableta+ 300 mg/1 tableta+ 245 mg/1 tableta filmom obložena tableta

merck sharp & dohme bh d.o.o. - doravirin, lamivudin, tenofovir disoproksil - filmom obložena tableta - 100 mg/1 tableta+ 300 mg/1 tableta+ 245 mg/1 tableta - 1 filmom obložena tableta sadrži: 100 mg doravirina, 300 mg lamivudina i 245 mg tenofovir disoproksila (u obliku 300 mg tenofovir disoproksil fumarata)

GHRYVELIN (previously Macimorelin Aeterna Zentaris) Europska Unija - hrvatski - EMA (European Medicines Agency)

ghryvelin (previously macimorelin aeterna zentaris)

atnahs pharma netherlands b.v. - macimorelin acetat - metode dijagnostike, endokrini - macimorelin - ovaj je lijek samo za dijagnostičku uporabu.  ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.

Maviret Europska Unija - hrvatski - EMA (European Medicines Agency)

maviret

abbvie deutschland gmbh co. kg - glecaprevir, pibrentasvir - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - maviret is indicated for the treatment of chronic hepatitis c virus (hcv) infection in adults and children aged 3 years and older. maviret coated granules is indicated for the treatment of chronic hepatitis c virus (hcv) infection in children 3 years and older.